New Insights into the Pathogenesis of Non-Alcoholic Fatty Liver Disease: Gut-Derived Lipopolysaccharides and Oxidative Stress
Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease worldwide. The intricate NAFLD pathogenesis is summarized by the multiple-hits hypothesis, which combines all the environmental and genetic factors that promote the development of NAFLD into a single scenario. Among t...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-09-01
|
Series: | Nutrients |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6643/12/9/2762 |
_version_ | 1797554063185805312 |
---|---|
author | Domenico Ferro Francesco Baratta Daniele Pastori Nicholas Cocomello Alessandra Colantoni Francesco Angelico Maria Del Ben |
author_facet | Domenico Ferro Francesco Baratta Daniele Pastori Nicholas Cocomello Alessandra Colantoni Francesco Angelico Maria Del Ben |
author_sort | Domenico Ferro |
collection | DOAJ |
description | Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease worldwide. The intricate NAFLD pathogenesis is summarized by the multiple-hits hypothesis, which combines all the environmental and genetic factors that promote the development of NAFLD into a single scenario. Among these, bacterial lipopolysaccharides (LPS) are derived from the overgrowth of Gram-negative bacteria and translocated mainly as a consequence of enhanced intestinal permeability. Furthermore, oxidative stress is increased in NAFLD as a consequence of reactive oxygen species (ROS) overproduction and a shortage of endogenous antioxidant molecules, and it is promoted by the interaction between LPS and the Toll-like receptor 4 system. Interestingly, oxidative stress, which has previously been described as being overexpressed in cardiovascular disease, could represent the link between LPS and the increased cardiovascular risk in NAFLD subjects. To date, the only effective strategy for the treatment of NAFLD and non-alcoholic steatohepatitis (NASH) is the loss of at least 5% body weight in overweight and/or obese subjects. However, the dose-dependent effects of multispecies probiotic supplementation on the serum LPS level and cardiometabolic profile in obese postmenopausal women were demonstrated. In addition, many antibiotics have regulatory effects on intestinal microbiota and were able to reduce serum aspartate aminotransferase (AST), alanine aminotransferase (ALT), and tumor necrosis factor alpha (TNF-α) in NASH animal models. Regarding the oxidant status, a Mediterranean diet has been reported to reduce oxidant stress, while vitamin E at high daily dosages induced the resolution of NASH in 36% of treated patients. Silymarin had the positive effect of reducing transaminase levels in NAFLD patients and long-term treatment may also decrease fibrosis and slow liver disease progression in NASH. Finally, the influence of nutraceuticals on gut microbiota and oxidant stress in NAFLD patients has not yet been well elucidated and there are insufficient data either to support or refuse their use in these subjects. |
first_indexed | 2024-03-10T16:25:29Z |
format | Article |
id | doaj.art-69e3bd3cf5764c4bacd46b817f35884d |
institution | Directory Open Access Journal |
issn | 2072-6643 |
language | English |
last_indexed | 2024-03-10T16:25:29Z |
publishDate | 2020-09-01 |
publisher | MDPI AG |
record_format | Article |
series | Nutrients |
spelling | doaj.art-69e3bd3cf5764c4bacd46b817f35884d2023-11-20T13:15:05ZengMDPI AGNutrients2072-66432020-09-01129276210.3390/nu12092762New Insights into the Pathogenesis of Non-Alcoholic Fatty Liver Disease: Gut-Derived Lipopolysaccharides and Oxidative StressDomenico Ferro0Francesco Baratta1Daniele Pastori2Nicholas Cocomello3Alessandra Colantoni4Francesco Angelico5Maria Del Ben6I Clinica Medica, Department of Clinical, Internal, Anesthetic and Cardiovascular Sciences, Sapienza University of Rome, 00185 Rome, ItalyI Clinica Medica, Department of Clinical, Internal, Anesthetic and Cardiovascular Sciences, Sapienza University of Rome, 00185 Rome, ItalyI Clinica Medica, Department of Clinical, Internal, Anesthetic and Cardiovascular Sciences, Sapienza University of Rome, 00185 Rome, ItalyI Clinica Medica, Department of Clinical, Internal, Anesthetic and Cardiovascular Sciences, Sapienza University of Rome, 00185 Rome, ItalyI Clinica Medica, Department of Clinical, Internal, Anesthetic and Cardiovascular Sciences, Sapienza University of Rome, 00185 Rome, ItalyDepartment of Public Health and Infectious Diseases, Sapienza University of Rome, 00185 Rome, ItalyI Clinica Medica, Department of Clinical, Internal, Anesthetic and Cardiovascular Sciences, Sapienza University of Rome, 00185 Rome, ItalyNon-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease worldwide. The intricate NAFLD pathogenesis is summarized by the multiple-hits hypothesis, which combines all the environmental and genetic factors that promote the development of NAFLD into a single scenario. Among these, bacterial lipopolysaccharides (LPS) are derived from the overgrowth of Gram-negative bacteria and translocated mainly as a consequence of enhanced intestinal permeability. Furthermore, oxidative stress is increased in NAFLD as a consequence of reactive oxygen species (ROS) overproduction and a shortage of endogenous antioxidant molecules, and it is promoted by the interaction between LPS and the Toll-like receptor 4 system. Interestingly, oxidative stress, which has previously been described as being overexpressed in cardiovascular disease, could represent the link between LPS and the increased cardiovascular risk in NAFLD subjects. To date, the only effective strategy for the treatment of NAFLD and non-alcoholic steatohepatitis (NASH) is the loss of at least 5% body weight in overweight and/or obese subjects. However, the dose-dependent effects of multispecies probiotic supplementation on the serum LPS level and cardiometabolic profile in obese postmenopausal women were demonstrated. In addition, many antibiotics have regulatory effects on intestinal microbiota and were able to reduce serum aspartate aminotransferase (AST), alanine aminotransferase (ALT), and tumor necrosis factor alpha (TNF-α) in NASH animal models. Regarding the oxidant status, a Mediterranean diet has been reported to reduce oxidant stress, while vitamin E at high daily dosages induced the resolution of NASH in 36% of treated patients. Silymarin had the positive effect of reducing transaminase levels in NAFLD patients and long-term treatment may also decrease fibrosis and slow liver disease progression in NASH. Finally, the influence of nutraceuticals on gut microbiota and oxidant stress in NAFLD patients has not yet been well elucidated and there are insufficient data either to support or refuse their use in these subjects.https://www.mdpi.com/2072-6643/12/9/2762non-alcoholic fatty liver diseaselipopolysaccharideoxidative stresscardiovascular risk |
spellingShingle | Domenico Ferro Francesco Baratta Daniele Pastori Nicholas Cocomello Alessandra Colantoni Francesco Angelico Maria Del Ben New Insights into the Pathogenesis of Non-Alcoholic Fatty Liver Disease: Gut-Derived Lipopolysaccharides and Oxidative Stress Nutrients non-alcoholic fatty liver disease lipopolysaccharide oxidative stress cardiovascular risk |
title | New Insights into the Pathogenesis of Non-Alcoholic Fatty Liver Disease: Gut-Derived Lipopolysaccharides and Oxidative Stress |
title_full | New Insights into the Pathogenesis of Non-Alcoholic Fatty Liver Disease: Gut-Derived Lipopolysaccharides and Oxidative Stress |
title_fullStr | New Insights into the Pathogenesis of Non-Alcoholic Fatty Liver Disease: Gut-Derived Lipopolysaccharides and Oxidative Stress |
title_full_unstemmed | New Insights into the Pathogenesis of Non-Alcoholic Fatty Liver Disease: Gut-Derived Lipopolysaccharides and Oxidative Stress |
title_short | New Insights into the Pathogenesis of Non-Alcoholic Fatty Liver Disease: Gut-Derived Lipopolysaccharides and Oxidative Stress |
title_sort | new insights into the pathogenesis of non alcoholic fatty liver disease gut derived lipopolysaccharides and oxidative stress |
topic | non-alcoholic fatty liver disease lipopolysaccharide oxidative stress cardiovascular risk |
url | https://www.mdpi.com/2072-6643/12/9/2762 |
work_keys_str_mv | AT domenicoferro newinsightsintothepathogenesisofnonalcoholicfattyliverdiseasegutderivedlipopolysaccharidesandoxidativestress AT francescobaratta newinsightsintothepathogenesisofnonalcoholicfattyliverdiseasegutderivedlipopolysaccharidesandoxidativestress AT danielepastori newinsightsintothepathogenesisofnonalcoholicfattyliverdiseasegutderivedlipopolysaccharidesandoxidativestress AT nicholascocomello newinsightsintothepathogenesisofnonalcoholicfattyliverdiseasegutderivedlipopolysaccharidesandoxidativestress AT alessandracolantoni newinsightsintothepathogenesisofnonalcoholicfattyliverdiseasegutderivedlipopolysaccharidesandoxidativestress AT francescoangelico newinsightsintothepathogenesisofnonalcoholicfattyliverdiseasegutderivedlipopolysaccharidesandoxidativestress AT mariadelben newinsightsintothepathogenesisofnonalcoholicfattyliverdiseasegutderivedlipopolysaccharidesandoxidativestress |